BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15942635)

  • 1. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.
    Leung WK; To KF; Chu ES; Chan MW; Bai AH; Ng EK; Chan FK; Sung JJ
    Br J Cancer; 2005 Jun; 92(12):2190-4. PubMed ID: 15942635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.
    Lee TL; Leung WK; Chan MW; Ng EK; Tong JH; Lo KW; Chung SC; Sung JJ; To KF
    Clin Cancer Res; 2002 Jun; 8(6):1761-6. PubMed ID: 12060614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of free tumor-related DNA in the serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Deng GR
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer.
    Ichikawa D; Koike H; Ikoma H; Ikoma D; Tani N; Otsuji E; Kitamura K; Yamagishi H
    Anticancer Res; 2004; 24(4):2477-81. PubMed ID: 15330201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between serum DNA methylation and prognosis in gastric cancer patients.
    Ikoma H; Ichikawa D; Koike H; Ikoma D; Tani N; Okamoto K; Ochiai T; Ueda Y; Otsuji E; Yamagishi H
    Anticancer Res; 2006; 26(3B):2313-6. PubMed ID: 16821608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprimo as a potential biomarker for early detection in gastric cancer.
    Bernal C; Aguayo F; Villarroel C; Vargas M; Díaz I; Ossandon FJ; Santibáñez E; Palma M; Aravena E; Barrientos C; Corvalan AH
    Clin Cancer Res; 2008 Oct; 14(19):6264-9. PubMed ID: 18829507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma.
    Ksiaa F; Ziadi S; Amara K; Korbi S; Trimeche M
    Clin Chim Acta; 2009 Jun; 404(2):128-33. PubMed ID: 19336228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C; Henrique R; Hoque MO; Mambo E; Ribeiro FR; Varzim G; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Clin Cancer Res; 2004 Dec; 10(24):8472-8. PubMed ID: 15623627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
    Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
    Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
    Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
    Wallner M; Herbst A; Behrens A; Crispin A; Stieber P; Göke B; Lamerz R; Kolligs FT
    Clin Cancer Res; 2006 Dec; 12(24):7347-52. PubMed ID: 17189406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
    Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
    Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of methylation specific-polymerase chain reaction in serum of patients with gastric cancer.
    Ikoma H; Ichikawa D; Daito I; Nobuyuki T; Koike H; Okamoto K; Ochiai T; Ueda Y; Yamagishi H; Otsuji E
    Hepatogastroenterology; 2007; 54(75):946-50. PubMed ID: 17591100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.